← All indications
Gastrointestinal Neoplasms
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
Subtype terms (5)
More specific conditions that are subtypes of Gastrointestinal Neoplasms in the MeSH hierarchy.
- Esophageal Neoplasms
750 drugs (232 approved, 518 experimental)
- Gastrointestinal Stromal Tumors
96 drugs (52 approved, 44 experimental)
- Intestinal Neoplasms
525 drugs (265 approved, 260 experimental)
- Stomach Neoplasms
873 drugs (262 approved, 611 experimental)
- Zollinger-Ellison Syndrome
15 drugs (12 approved, 3 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (9)
Phase 3 trials (19)
Phase 2 trials (96)
- azacitidine
- vitamin d3
- afatinib
- avatrombopag
- anlotinib
- rilotumumab
- atezolizumab
- acetylcysteine
- autologous tumor infiltrating lymphocytes
- azd9150
- brigatinib
- bvd-523
- amg-337
- cobimetinib
- doxorubicin
- entrectinib
- ganitumab
- vismodegib
- gemcitabine
- paclitaxel
- hydroxychloroquine
- aldesleukin
- palonosetron
- Imetelstat
- imu-131
- Filgrastim
- nivolumab
- ipatasertib
- itacitinib
- lurbinectedin
- +66 more
Phase 1 trials (31)
- bi 754091
- blu-667
- brivanib alaninate
- cgx1321
- colloidal gold-bound tumor necrosis factor
- prednisone
- bemarituzumab
- igf-methotrexate
- indocyanine green
- vincristine
- picoplatin
- propranolol
- methylene blue
- sacituzumab govitecan
- sildenafil
- tumour infiltrating lymphocytes
- psilocybin
- tamoxifen
- neratinib maleate
- xmab18087
- rgx-202
- grt-c903
- hx008
- bi 905711
- oh2
- bi 765049
- arb202
- bgt007
- eo-3021
- 68ga-pmd22
- +1 more
Organizations
Organization Involved with Phase 4 Indications (18)
- Fresenius
- Pfizer
- Les Laboratoires des Médicaments Stériles
- Cedars-Sinai Medical Center
- King Faisal University
- Nanjing University
- University of Bern
- Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
- Dalian Medical University
- University of Copenhagen
- Royal Marsden Hospital NHS Trust
- King Faisal Specialist Hospital
- Charle Nicolle Hospital
- University of Paris
- National Natural Science Foundation of China
- People's Liberation Army of China
- Chinese Academy of Medical Sciences
- Jinlin University
Organization Involved with Phase 3 Indications (23)
- Abbott
- Celgene
- AstraZeneca
- Genentech
- Sanofi
- Novartis
- GlaxoSmithKline
- Auron Healthcare GmbH
- Ortho Pharmaceuticals
- National Cancer Institute (NCI)
- Blokhin's Russian Cancer Research Center
- Nanjing Medical University
- Aichi Medical University
- Epidemiological and Clinical Research Information Network
- Fudan University
- University of California, San Francisco
- University of Ulsan
- University of Freiburg
- Tianjin Medical University
- Sun Yat-Sen University
- University of Texas at Houston
- Sungkyunkwan University
- Johnson and Johnson
Organization Involved with Phase 2 Indications (103)
- 4SC AG
- Boston Biomedical
- Daiichi Sankyo
- Bristol-Myers Squibb
- Amgen
- Roche
- Merck
- Eli Lilly
- Exelixis
- Merck KGaA
- Aventis
- Sanofi-Synthelabo
- Ipsen
- AIO-Studien-gGmbH
- Apceth GmbH & Co. KG
- Catalysis SL
- FeRx
- Hengrui Therapeutics, Inc.
- Imugene Limited
- InnoPharmax Inc.
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- Pharmacia
- Shenzhen Hornetcorn Bio-technology Company, LTD
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Themis Bioscience GmbH
- Boehringer Ingelheim
- Transgene
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institutes of Health (NIH)
- British Columbia Cancer Agency
- +73 more
Organization Involved with Phase 1 Indications (42)
- Poniard Pharmaceuticals
- Seattle Genetics
- Millennium Pharmaceuticals
- Pharmacyclics
- Wyeth
- BioMed Valley Discoveries, Inc
- Blueprint Medicines Corporation
- Curegenix Inc.
- Handok Pharmaceuticals Co., Ltd.
- IGF Oncology, LLC
- Jeil Pharmaceutical Co., Ltd.
- Leadiant Biosciences, Inc.
- Minneamrita Therapeutics LLC
- Inspirna, Inc.
- Syndax Pharmaceuticals
- Teclison Ltd.
- Otsuka
- Fondazione Giovanni Pascale
- Central South University
- Baylor University
- Rhode Island Hospital
- University of Groningen
- University of Nottingham
- Virginia Commonwealth University
- Yale University
- University of Virginia
- Vanderbilt University
- CJ HealthCare Corp.
- Free University of Amsterdam
- Xencor
- +12 more
Organization Involved with Other Experimental Indications (12)